One of our strategic pillars is developing and growing our market leading positions. We supplement our organic growth by successfully acquiring and integrating complementary businesses which strengthen our market positions.

We acquired Canale Communications, an award-winning San Diego-based strategic communications agency.
Visit website
We acquired Incisive Health, a UK-based healthcare communications consultancy, which specialises in healthcare policy, public affairs and communication services.
Visit website
We acquired Putnam Associates, a US-based specialist consultancy focused on product commercialisation strategy, exclusively for the life sciences industry.
Visit website
We acquired Create NYC, a New York-based disruptive creative communications agency offering the tactical execution of sales and marketing materials for its international pharmaceutical clients.
Visit website
The acquisition of SmartAnalyst, a New York-based strategic commercialisation consulting and analytics business, focused on the pharmaceutical and biotech sector.
Visit website

The acquisition of Vynamic, a US-based healthcare industry management consultancy, further strengthened and expanded our Advisory offering.
Visit website
We acquired Cambridge Biomarketing, a full-service advertising and communications agency focused on orphan diseases and specialty markets.
Visit website
Our final acquisition of 2017 was the acquisition of MicroMass Communications, a US-based healthcare communications agency specialising in behavioural change.
Visit website
The acquisition of STEM Marketing was our first move into the Advisory space. STEM is the leading global provider of commercial, marketing and medical audits to pharmaceutical companies.
Visit website
In 2016, we acquired Pegasus, one of the most successful integrated healthcare communications consultancies in the UK.
Visit website
We formalised our joint venture with CMIC in 2015, creating CMIC Ashfield, a contract sales solution in Japan.
Visit website



Through the acquisition of Pharmexx, we added true international reach and depth to our contract sales capabilities through our expansion into 8 new countries.
Visit website
The acquisition of Bilcare in the US and the UK added clinical trial and supply chain packaging expertise to our packaging portfolio.
Visit website